about
Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular DeliverySingle ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV modelImproved retinal function in RCS rats after suppressing the over-activation of mGluR5Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedlesNovel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept.Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucomaCircumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries.Visual tracing of diffusion and biodistribution for amphiphilic cationic nanoparticles using photoacoustic imaging after ex vivo intravitreal injectionsG-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye.Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunitiesNanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.Development of microemulsions for ocular delivery.Assessing the systemic toxicity in rabbits after sub acute exposure to ocular irritant chemicals.In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.Ocular delivery of proteins and peptides: challenges and novel formulation approaches.Photo-Modulated Therapeutic Protein Release from a Hydrogel Depot Using Visible Light.Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera.Application of Hydrogel Template Strategy in Ocular Drug Delivery.How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches.Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular.Controlled and Extended In Vitro Release of Bioactive Anti-Vascular Endothelial Growth Factors from a Microsphere-Hydrogel Drug Delivery System.Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle.PLGA nanoparticles for intravitreal peptide delivery: statistical optimization, characterization and toxicity evaluation.Targeted Drug Delivery in the Suprachoroidal Space by Swollen Hydrogel Pushing.Nanotechnology in retinal drug delivery.Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
P2860
Q26740005-5DA7F723-4BEE-4E34-9AB9-175A56FF01C3Q32172336-C488E385-986B-4519-B4A1-34F5C13C726BQ33799156-45857A96-910C-4857-85E7-0D147B0F2A16Q36157157-85E07D80-5D73-45E5-A8C3-3C8E806A6655Q36674580-9E24F2BC-031A-4FC3-B5D4-2D488C08DAB4Q36788792-A76779B1-08AE-445A-BA8E-6642B4B306BEQ36828342-F3CC8BDD-22A2-416E-9B72-285DC76CA250Q37338088-CD88380E-09A8-4463-AC14-E46E5EB951B6Q37677464-D2438DC6-1940-4170-AFE7-13CDDFA85265Q38769853-1DA794F2-9DD0-42CA-A597-DBE4EF68AFB6Q38787324-73240DFD-A5EF-4F6B-B78D-A99B08C1446AQ38829320-06D53B21-E168-4A8C-A864-D8061D1AB30FQ39087808-5D616B25-2A83-445D-9C09-AA3E133EFD65Q39210541-D2A0CA7D-125C-41AB-834C-437DD7645AF7Q39595850-B9D6D292-B9E1-4285-89D9-B119EEE04825Q39767319-09A80C9A-B211-4EE7-AA64-5F0330DB3FD1Q47442388-09609A63-751A-4DA5-8132-A03F32933BE1Q47729137-4EFBDCE1-2EFC-4F22-9DEF-AC161D7091ADQ48180462-FEBB6D84-FBDC-454F-AAD5-77BA1C18CDD7Q48238962-42A331CD-2B9B-424E-8F1F-714924702855Q48821505-DE231C0B-53A8-420A-8A5A-0AF2B62B09E7Q48902538-EB773BB1-026D-4437-9DF2-95E35641A5F6Q49628598-6DC49F95-ABEB-4B80-853B-8A29318E244DQ51562739-A30924A0-E71D-46EB-9A43-CDAEC33287D1Q52673868-ADEEE078-E7B4-48E1-AB8A-FEB8231E8865Q54195898-3B74543E-B980-4759-84E5-1562274E1E2FQ55315376-856FAEF0-E5DC-4076-811A-28DD297C4C02Q55491207-521505C7-EB86-481E-BC18-331A7D85D7EDQ58716234-BC1EDF05-818B-47C4-B092-494F919BFAEF
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ocular delivery of macromolecules
@ast
Ocular delivery of macromolecules
@en
Ocular delivery of macromolecules
@nl
type
label
Ocular delivery of macromolecules
@ast
Ocular delivery of macromolecules
@en
Ocular delivery of macromolecules
@nl
prefLabel
Ocular delivery of macromolecules
@ast
Ocular delivery of macromolecules
@en
Ocular delivery of macromolecules
@nl
P2093
P2860
P1476
Ocular delivery of macromolecules
@en
P2093
Bryce Chiang
Mark R Prausnitz
Xianggen Wu
Yoo Chun Kim
P2860
P304
P356
10.1016/J.JCONREL.2014.06.043
P407
P577
2014-07-03T00:00:00Z